Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OC000459 dose-finding study in grass pollen allergic rhinitis
2008-001659-24Phase 2Completed
- Sponsor
- Oxagen
- Start
- Apr 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in allergic rhinitis (AR) comparing OC000459 with Placebo (2 arms). Primary endpoint: Primary efficacy endpoint. Started Apr 2008; status: completed.
02
Drugs
timapiprant
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on 2008-001659-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-001659-24.